Table 2.
Psychiatric medication and medication class search terms
| Antidepressants | MAOI | Chlorpromazine | Psychostimulants for treatment of ADHD and narcolepsy | Naltrexone |
| Antidepressant | Monoamine oxidase inhibitor | Fluphenazine | Varenicline | |
| TCA | Haloperidol | Methadone | ||
| Tricyclic antidepressant | Isocarboxazid | Loxapine | Psychostimulant | Buprenorphine |
| Desipramine | Phenelzine | Perphenazine | Stimulant | MDD & PTSD EU/International pharmacotherapy |
| Nortriptyline | Selegiline | Pimozide | Amphetamine | |
| Protriptyline | Tranylcypromine | Thioridazine | Dextroamphetamine | |
| Amitriptyline | NMDA antagonist | Thiothixene | Armodafinil | reboxetine |
| Clomipramine | Ketamine | Trifluoperazine | Modafinil | viloxazine |
| Doxepin | Esketamine | Second generation antipsychotic | Dextroamphetamine | dibenzepin |
| Imipramine | Anxiolytics | Lisdexamfetamine | dimetacrine | |
| Trimipramine | Anxiolytics | Atypical antipsychotic | Methamphetamine | dosulepin |
| Amoxapine | Benzodiazepine | Aripiprazole | Dexmethylphenidate | lofepramine |
| Maprotiline | Alprazolam | Asenapine | Methylphenidate | melitracen |
| SSRI | Chlordiazepoxide | Brexpiprazole | Non-psychostimulants for treatment of ADHD | nitroxazepine |
| Serotonin reuptake inhibitor | Clonazepam | Cariprazine | noxiptiline | |
| Clorazepate | Clozapine | Atomoxetine | pipofezine | |
| Citalopram | Diazepam | Iloperidone | Clonidine | maprotiline |
| Escitalopram | Lorazepam | Lurasidone | Guanfacine | mianserin |
| Fluoxetine | Oxazepam | Olanzapine | Agents for cognitive disorders | setiptiline |
| Fluvoxamine | Buspirone | Paliperidone | moclobemide | |
| Paroxetine | Agents for treatment of insomnia | Invega Sustenna | Donepezil | pirlindole |
| Sertraline | Invega Trinza | Galantamine | toloxatone | |
| SNRI | Estazolam | Quetiapine | Memantine | agomelatine |
| Serotonin norepinephrine reuptake inhibitor | Flurazepam | Risperidone | Rivastigmine | tandospirone |
| Quazepam | Ziprasidone | Agents for treatment of antipsychotic-induced extrapyramidal side effects | tianeptine | |
| Desvenlafaxine | Temazepam | Mood stabilizers | Additional Adjunctive PTSD & MDD pharmacotherapy | |
| Duloxetine | Triazolam | Mood stabilizer | ||
| Levomilnacipran | Eszopiclone | Carbamazepine | ||
| Milnacipran | Ramelteon | Gabapentin | Amantadine | PTSD |
| Venlafaxine | Suvorexant | Lamotrigine | Benztropine | Prazosin |
| Norepinephrine dopamine reuptake inhibitor | Tasimelteon | Lithium | Diphenhydramine | MDD |
| Zaleplon | Oxcarbazepine | Propranolol | Liothyronine | |
| NDRI | Zolpidem | Pregabalin | Trihexyphenidyl | St. Johns Wort |
| Bupropion | Antipsychotics | Topiramate | Agents for treatment of substance use disorders | |
| Aplenzin | First generation antipsychotic | Valproate | ||
| Nefazodone | Divalproex | Acamprosate | ||
| Trazodone | Antipsychotic | Depakote | Disulfiram | |
| Vortioxetine | Typical antipsychotic | |||
| Vilazodone | ||||
| Mirtazapine |